Literature DB >> 7811274

A novel cyclic GMP stimulated phosphodiesterase from rat brain.

Q Yang1, M Paskind, G Bolger, W J Thompson, D R Repaske, L S Cutler, P M Epstein.   

Abstract

A cDNA clone for cyclic GMP Stimulated Phosphodiesterase (cGSPDE; PDE2) was isolated from a rat brain cDNA library. The cDNA has an open reading frame which encodes a protein of 928 amino acids of which 829 are identical with the reported bovine adrenal gland cGSPDE cDNA (Sonnenburg, W.K., Mullaney, P.J., and Beavo, J.A. (1991) J. Biol. Chem. 266, 17655-17661). Although the overall homology of these two cDNAs is high, they are distinctly different in their 5' ends, with the N-terminal 37 amino acids of the rat brain protein showing no homology with the N-terminal end of the bovine adrenal protein. Hydrophilicity plots show that in contrast to the bovine adrenal cGSPDE, the N-terminal end of the rat brain cGSPDE is highly hydrophobic. Isolation and analysis of a genomic clone for cGSPDE from a rat genomic library shows the presence of an exon/intron junction at the Gln39 codon. The cGSPDE cDNA we have isolated and that of Sonnenburg et al. represent alternatively spliced mRNA products from the same gene, with the brain isoform designed to be targeted to membranes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7811274     DOI: 10.1006/bbrc.1994.2886

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

2.  A phosphodiesterase 2A isoform localized to mitochondria regulates respiration.

Authors:  Rebeca Acin-Perez; Michael Russwurm; Kathrin Günnewig; Melanie Gertz; Georg Zoidl; Lavoisier Ramos; Jochen Buck; Lonny R Levin; Joachim Rassow; Giovanni Manfredi; Clemens Steegborn
Journal:  J Biol Chem       Date:  2011-07-01       Impact factor: 5.157

Review 3.  Clinical and molecular genetics of the phosphodiesterases (PDEs).

Authors:  Monalisa F Azevedo; Fabio R Faucz; Eirini Bimpaki; Anelia Horvath; Isaac Levy; Rodrigo B de Alexandre; Faiyaz Ahmad; Vincent Manganiello; Constantine A Stratakis
Journal:  Endocr Rev       Date:  2013-12-05       Impact factor: 19.871

4.  Selective up-regulation of PDE1B2 upon monocyte-to-macrophage differentiation.

Authors:  Andrew T Bender; Cari L Ostenson; Edith H Wang; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-29       Impact factor: 11.205

Review 5.  Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure.

Authors:  Rima Kamel; Jérôme Leroy; Grégoire Vandecasteele; Rodolphe Fischmeister
Journal:  Nat Rev Cardiol       Date:  2022-09-01       Impact factor: 49.421

6.  Inhibition of calmodulin-dependent phosphodiesterase induces apoptosis in human leukemic cells.

Authors:  X Jiang; J Li; M Paskind; P M Epstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  The distribution of phosphodiesterase 2A in the rat brain.

Authors:  D T Stephenson; T M Coskran; M P Kelly; R J Kleiman; D Morton; S M O'Neill; C J Schmidt; R J Weinberg; F S Menniti
Journal:  Neuroscience       Date:  2012-09-19       Impact factor: 3.590

Review 8.  Targeting phosphodiesterases in anti-platelet therapy.

Authors:  Matthew T Rondina; Andrew S Weyrich
Journal:  Handb Exp Pharmacol       Date:  2012

9.  Dual acylation of PDE2A splice variant 3: targeting to synaptic membranes.

Authors:  Corina Russwurm; Georg Zoidl; Doris Koesling; Michael Russwurm
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

10.  Cyclic AMP compartments and signaling specificity: role of cyclic nucleotide phosphodiesterases.

Authors:  Marco Conti; Delphine Mika; Wito Richter
Journal:  J Gen Physiol       Date:  2014-01       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.